Among patients with ADRD receiving care from a home health agency, antipsychotic use was tied to less improvement in activities of daily living.
News and Features
Comparable rates of in-hospital adverse events seen among seniors prescribed oral antipsychotics after major surgery
Proposal would set minimum staffing to equivalent of 3 hours per resident per day, with just over a half hour of that time from a registered nurse.
Izervay is expected to be available in 2 to 4 weeks.
The investigational RSV vaccine consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.
Arexvy is expected to be available for the 2023-2024 RSV season.
Strongest association seen for quercetin subclass of flavonols, but no association seen for total flavonoid intake.
Abrysvo is expected to be available in the third quarter of 2023.
Most respondents indicated a desire for use of a real-time benefit tool, with concern reported regarding inaccurate prices.
Participants with lower bone mineral density at femoral neck more likely to develop all-cause dementia, Alzheimer disease during follow-up.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
The FDA panel reviewed data from 5 clinical studies, including the phase 3 AReSVi 006 trial.
High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions
ACP is an investigational complement C5 inhibitor that is designed to decrease the activation of inflammasomes and the formation of membrane attack complex.
No such association seen for Black older adults followed for 15 years, regardless of sleep duration
Vaccination results in lower RSV-mediated lower respiratory tract disease meeting one of three definitions
Authors say providers should routinely ask older adults about cannabis use
But polypill with or without aspirin is associated with reduced functional decline for those aged 65 years or older with cardiovascular risk factors